Market Research Future
Clinical Laboratory Services Market is set to touch a valuation of USD 274450 Mn during the forecast period 2018 to 2023 Contract Research Organization Market - Scenario According to Market Research Future (MRFR)’s analysis, the global clinical laboratory services market is set to touch a valuation of USD 274450 Mn during the forecast period 2018 to 2023. The rising burden of chronic diseases such as cancer, diabetes, etc. is poised to dictate the growth trajectory of the global market in the forthcoming years. Rising awareness about diseases has fueled demand for early diagnosis. This, in turn, has led to a drastic increase in expenditures for preventive healthcare. It is projected to catalyze the growth of the clinical laboratory services market across the projection period. Investments are anticipated to flow towards the development of advanced tests with higher precision and accuracy. The rapid developments in the healthcare sector coupled with extensive research & development is presumed to encourage the proliferation of the market in the foreseeable future. Innovation is the key focus for the market participants. They are strategizing mergers & acquisitions, collaborations, etc. for the acceleration of revenue creation. The market has been predicted to remain lucrative through the projection period. Request Sample Copy at https://www.marketresearchfuture.com/sample_request/7145 Players Covered: Some of the prominent players operating in the global clinical laboratory services market are Mayo Medical Laboratories, Quest Diagnostics Incorporated, Spectra Laboratories Inc, Laboratory Corporation of America Holdings, Eurofins Scientific, Unilabs, Bio-Reference Laboratories, Synlab International, Sonic Healthcare, ACM Medical Laboratory, Cerba Healthcare, Clinical Reference Laboratory, Amedes Holdings, Adicon Clinical Laboratory, and Lifelabs Medicals Laboratories. Segments: This MRFR report offers a detailed segmental analysis of the global clinical laboratory services market based on type and application. By type, the market is segmented into biochemistry, endocrinology, microbiology, hematology, histopathology, cytology, genetic testing, and others. Among these, the hematology segment held 25.6% market share in 2017. It is estimated to retain its dominant position through the forecast period. The growth of the segment can be ascribed to the large-scale prevalence of blood cancer. As per the 2018 statistics revealed by the Leukemia & Lymphoma Society, around 60,300 people are projected to be diagnosed with leukemia, whereas, 24,370 people are expected to succumb to the disease.